CA
THC icon

CoreCap Advisors’s Tenet Healthcare THC Stock Holding History

CoreCap Advisors’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2K Buy
92
+43
+88% +$7.91K ﹤0.01% 1865
2026
Q1 		$9.25K Sell
49
-49
-50% -$10.3K ﹤0.01% 1974
2025
Q4 		$19.5K Sell
98
-333
-77% -$67.3K ﹤0.01% 1692
2025
Q3 		$87.5K Buy
431
+255
+145% +$45.2K ﹤0.01% 1087
2025
Q2 		$31K Buy
176
+81
+85% +$12.2K ﹤0.01% 1442
2025
Q1 		$12.8K Sell
95
-117
-55% -$15.4K ﹤0.01% 1712
2024
Q4 		$26.8K Sell
212
-162
-43% -$24.1K ﹤0.01% 1434
2024
Q3 		$62.2K Sell
374
-484
-56% -$73.2K ﹤0.01% 1106
2024
Q2 		$114K Buy
858
+84
+11% +$10.1K 0.01% 469
2024
Q1 		$81.4K Buy
+774
New +$69.5K ﹤0.01% 920
2022
Q4 		$61.6K Buy
+1,263
New +$58.4K ﹤0.01% 922
2022
Q3 		– Sell
-736
Closed -$39K – 1930
2022
Q2 		$39K Buy
+736
New +$51.2K ﹤0.01% 1017
2022
Q1 		– Sell
-1,766
Closed -$144K – 1931
2021
Q4 		$144K Buy
+1,766
New +$129K 0.01% 627

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

CoreCap Advisors's THC Position: Q2 2026 in Review

CoreCap Advisors increased its Tenet Healthcare (THC) stake by 88% in Q2 2026, buying an estimated $7.91K and bringing the position to 92 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

CoreCap Advisors first reported a position in THC in Q4 2021 and has held it in 13 quarters since. The position peaked at $144K in Q4 2021. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • CoreCap Advisors held 92 shares of Tenet Healthcare worth $17.2K as of Q2 2026.
  • CoreCap Advisors bought 43 Tenet Healthcare shares in Q2 2026, an estimated $7.91K.
  • Tenet Healthcare made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1865 holding.
  • CoreCap Advisors first reported a position in Tenet Healthcare in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's Tenet Healthcare position peaked at $144K in Q4 2021.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.